Drug × Cancer matrix

Each row is a drug, each column a cancer subtype. Cells show the strongest known association for that drug in that cancer: approved clinical trial or blank. The repositionable flag means the drug appears as a synthetic-lethal repositioning candidate in cansar; it’s gene-level, not cancer-level.

Cancer key
GBM — Glioblastoma (CNS astrocytoma grade IV) LUAD — Lung adenocarcinoma SCLC — Small cell lung carcinoma LUSC — Lung squamous cell carcinoma OAC — Oesophageal adenocarcinoma OSCC — Oesophageal squamous cell carcinoma PDAC — Pancreatic ductal adenocarcinoma
Clear
Showing 61 of 61 matching drugs for TUBA1B — including drugs targeting any of its 19 synthetic-lethal partners , sorted by total cancer coverage.
Drug Target Relationship GBM LUAD SCLC LUSC OAC OSCC PDAC Reposition #cancers
patupilone TUBA1B Direct 1
belantamab mafodotin TUBA1B Direct yes 0
docetaxel TUBA1B Direct yes 0
eribulin TUBA1B Direct yes 0
eribulin mesylate TUBA1B Direct yes 0
vinblastine TUBA1B Direct yes 0
vinblastine sulfate TUBA1B Direct yes 0
vincristine TUBA1B Direct yes 0
vincristine sulfate TUBA1B Direct yes 0
vinorelbine TUBA1B Direct yes 0
vinorelbine tartrate TUBA1B Direct yes 0
adagrasib KRAS SSL via KRAS yes 2
afatinib EGFR SSL via EGFR yes 2
dacomitinib EGFR SSL via EGFR yes 2
erlotinib EGFR SSL via EGFR yes 2
gefitinib EGFR SSL via EGFR yes 2
sotorasib KRAS SSL via KRAS yes 2
lazertinib and amivantamab EGFR SSL via EGFR 1
osimertinib EGFR SSL via EGFR yes 1
vinorelbine, cisplatin, vinorelbine, cisplatin, radiotherapy TUBB SSL via TUBB 2
ce-mark approved laa closure devices, acetylsalicylic acid, clopidogrel, dabigatran, rivaroxaban, apixaban, edoxaban, phenprocoumon, warfarin HSPA5 SSL via HSPA5 1
concomitant temozolomide (tmz), radiotherapy, procarbazine, adjuvant temozolomide (tmz), ccnu, vincristine TUBB SSL via TUBB 1
dabrafenib, trametinib, carboplatin, vincristine TUBB SSL via TUBB 1
depatuxizumab mafodotin, temozolomide, lomustine TUBB SSL via TUBB 1
disulfiram, copper, alkylating agents HSPA5 SSL via HSPA5 1
disulfiram, copper, alkylating agents PRDX1 SSL via PRDX1 1
disulfiram, copper, alkylating agents TUBB SSL via TUBB 1
docetaxel, cisplatin, radiation, surgery, vinorelbine, cisplatin TUBB SSL via TUBB 1
gemcitabine, vinorelbine, cisplatin, etoposide, carboplatin TUBB SSL via TUBB 1
mebendazole, vincristine, carboplatin, temozolomide, bevacizumab, irinotecan TUBB SSL via TUBB 1
patupilone TUBB SSL via TUBB 1
recombinant interferon alfa-2b, cisplatin, sodium stibogluconate, dacarbazine, vinblastine TUBB SSL via TUBB 1
temozolomide, depatuxizumab mafodotin, radiation, placebo for abt-414 TUBB SSL via TUBB 1
trametinib, vinblastine TUBB SSL via TUBB 1
vinorelbine TUBB SSL via TUBB yes 1
vinorelbine, xr9576 TUBB SSL via TUBB 1
afatinib dimaleate EGFR SSL via EGFR yes 0
belantamab mafodotin TUBB SSL via TUBB yes 0
cabazitaxel TUBB SSL via TUBB yes 0
cetuximab EGFR SSL via EGFR yes 0
docetaxel TUBB SSL via TUBB yes 0
eribulin TUBB SSL via TUBB yes 0
eribulin mesylate TUBB SSL via TUBB yes 0
erlotinib hydrochloride EGFR SSL via EGFR yes 0
lapatinib EGFR SSL via EGFR yes 0
lapatinib ditosylate EGFR SSL via EGFR yes 0
necitumumab EGFR SSL via EGFR yes 0
neratinib EGFR SSL via EGFR yes 0
neratinib maleate EGFR SSL via EGFR yes 0
osimertinib mesylate EGFR SSL via EGFR yes 0
panitumumab EGFR SSL via EGFR yes 0
regorafenib EGFR SSL via EGFR yes 0
vandetanib EGFR SSL via EGFR yes 0
vinblastine TUBB SSL via TUBB yes 0
vinblastine sulfate TUBB SSL via TUBB yes 0
vincristine TUBB SSL via TUBB yes 0
vincristine sulfate TUBB SSL via TUBB yes 0
vindesine TUBB SSL via TUBB yes 0
vindesine sulfate TUBB SSL via TUBB yes 0
vinflunine TUBB SSL via TUBB yes 0
vinorelbine tartrate TUBB SSL via TUBB yes 0
Approval data manually curated from National Cancer Institute and Drugs@FDA. Clinical trials from ClinicalTrials.gov. Repositionable list from cansar.ai.